Video index

1. Call to order

2. Consideration of April 24, 2024, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL (Part 1 of 2)

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL (Part 2 of 2)

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Retrospective drug utilization review (DUR): Acentra Health

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: October 25, 2024, 9:00 a.m

Jul 26, 2024 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

2. Consideration of April 24, 2024, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL (Part 1 of 2)

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL (Part 2 of 2)

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Retrospective drug utilization review (DUR): Acentra Health

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: October 25, 2024, 9:00 a.m

© 2003-2024 Swagit Productions, LLC